Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | METHYLERGONOVINE MALEATE |
| Generic name | METHYLERGONOVINE |
| Active ingredient(s) | METHYLERGONOVINE MALEATE |
| Distributed by / for | Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807 |
| NDC | 69238-1605-2 |
| Full product label | Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807, NDC # 69238-1605-2. |
| Recalling firm | Amneal Pharmaceuticals of New York, LLC |
| Distribution | US Nationwide. |
| Quantity | 2784 bottles |
| Recall initiated | 2024-03-25 |
| Report date | 2024-05-08 |
| Recall completed | — |
| Recall number | D-0477-2024 |
| Classification | Class II |
| FDA status | Completed |
| Origin on file | Brookhaven NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗